Abstract
Indiscriminately suppressing total c-Jun N-terminal kinase (JNK) activity is not an appropriate strategy because each JNK appears to have a distinct function in cancer, asthma, diabetes, or Parkinson's disease. Herein, we report that 7-(6-N-phenylaminohexyl)amino-2H-anthra[1,9-cd]pyrazol-6-one (AV-7) inhibited JNK1 activity, but not JNK2 or JNK3. We found that ultraviolet B (UVB) induced c-Jun phosphorylation and sub-G1 accumulation in JNK2(-/-) murine embryonic fibroblasts, which contain an abundance of JNK1, but not JNK2. These results demonstrate that AV-7 is an isoform selective small-molecule inhibitor of JNK1 activity, which might be developed as a therapeutic against diabetes.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aniline Compounds / chemistry*
-
Animals
-
Cells, Cultured
-
Embryo, Mammalian / metabolism
-
Humans
-
Mice
-
Mice, Knockout
-
Mitogen-Activated Protein Kinase 10 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 10 / genetics
-
Mitogen-Activated Protein Kinase 10 / metabolism
-
Mitogen-Activated Protein Kinase 8 / antagonists & inhibitors*
-
Mitogen-Activated Protein Kinase 8 / genetics
-
Mitogen-Activated Protein Kinase 8 / metabolism
-
Mitogen-Activated Protein Kinase 9 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 9 / genetics
-
Mitogen-Activated Protein Kinase 9 / metabolism
-
Phosphorylation
-
Protein Kinase Inhibitors / chemistry*
-
Pyrazoles / chemistry*
-
Ultraviolet Rays
Substances
-
7-(6-N-phenylaminohexyl)amino-2H-anthra(1,9-cd)pyrazol-6-one
-
Aniline Compounds
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Mitogen-Activated Protein Kinase 10
-
Mitogen-Activated Protein Kinase 9
-
Mitogen-Activated Protein Kinase 8